◄ back to all posts
Financial data and stock pages provided by
Fintel.io
Will “Go Crazy” Drive The Bear Out Of Hibernation?
Feb 24, 2021
◄ back to all posts
NVS: Novartis AG Stock
Written by | Jul 6, 2018
Print FriendlySIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 211,945.20 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | n/a |
| Book Value / Share | n/a |
| Price / Book | n/a |
| NCAV ($M) | n/a |
| NCAV / Share | n/a |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | n/a |
| Current Ratio | n/a |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | n/a |
| Assets | n/a |
| Liabilities | n/a |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | n/a |
| Operating Income | n/a |
| Net Income | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | n/a |
| Cash from Investing | n/a |
| Cash from Financing | n/a |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 300,104 | 2,230,100 | 13.46 | |
| 381,162 | 2,110,133 | 18.06 | |
| 214,113 | 2,571,200 | 8.33 | |
| 216,968 | 2,119,200 | 10.24 | |
(click for more detail) |
|||
(click for list of largest short owners) |
|||
| Similar Companies | |
|---|---|
| MRK – Merck & Co., Inc. | NUVB – Nuvation Bio Inc. |
| NVO – Novo-Nordisk A/S | PBH – Prestige Brands Holdings, Inc. |
| PFE – Pfizer, Inc. |
Financial data and stock pages provided by
Fintel.io
2018/07/06
Also Read
